Table of Contents
CHAPTER 1 INTRODUCTION
- 1.1 What is this report about?
- 1.2 Who is the target reader?
- 1.3 How to use this report
- 1.4 Definitions
CHAPTER 2 NAFTA COUNTRIES OTC PHARMACEUTICALS INDUSTRY OUTLOOK
CHAPTER 3 OTC PHARMACEUTICALS IN UNITED STATES
- 3.1 Market Overview
- 3.2 Market Value
- 3.3 Market Segmentation I
- 3.4 Market Segmentation II
- 3.5 Market Share
- 3.6 Five Forces Analysis
- 3.7 Leading Companies
- 3.8 Distribution
- 3.9 Market Forecasts
- 3.10 Macroeconomic Indicators
CHAPTER 4 OTC PHARMACEUTICALS IN MEXICO
- 4.1 Market Overview
- 4.2 Market Value
- 4.3 Market Segmentation I
- 4.4 Market Segmentation II
- 4.5 Market Share
- 4.6 Five Forces Analysis
- 4.7 Leading Companies
- 4.8 Distribution
- 4.9 Market Forecasts
- 4.10 Macroeconomic Indicators
CHAPTER 5 OTC PHARMACEUTICALS IN CANADA
- 5.1 Market Overview
- 5.2 Market Value
- 5.3 Market Segmentation I
- 5.4 Market Segmentation II
- 5.5 Market Share
- 5.6 Five Forces Analysis
- 5.7 Leading Companies
- 5.8 Distribution
- 5.9 Market Forecasts
- 5.10 Macroeconomic Indicators
CHAPTER 6 APPENDIX
- 6.1 Data Research Methodology
LIST OF TABLES
- Table 1: NAFTA countries OTC Pharmaceuticals industry, revenue ($bn) 2004
- 2013 12
- Table 2: NAFTA countries OTC Pharmaceuticals industry, revenue ($ bn) 2004
- 2008(e) 13
- Table 3: NAFTA countries OTC Pharmaceuticals industry forecast, revenue ($
bn) 2008 -
- 2013 14
- Table 4: United States OTC Pharmaceuticals Market Value: $ billion,
2004-2008(e) 16
- Table 5: United States OTC Pharmaceuticals Market Segmentation I: % Share,
by Value,
- 2008(e) 17
- Table 6: United States OTC Pharmaceuticals Market Segmentation II: %
Share, by Value,
- 2008(e) 18
- Table 7: United States OTC Pharmaceuticals Market Share: % Share, by
Value, 2007 19
- Table 8: Key Facts: Pfizer Inc 27
- Table 9: Key Financials: Pfizer Inc 29
- Table 10: Key Facts: GlaxoSmithKline Plc 30
- Table 11: Key Financials: GlaxoSmithKline Plc 33
- Table 12: Key Facts: Wyeth 34
- Table 13: Key Financials: Wyeth 36
- Table 14: United States OTC Pharmaceuticals Distribution: % Share, by
Value, 2008(e) 37
- Table 15: United States OTC Pharmaceuticals Market Value Forecast: $
billion, 2008-
- 2013 38
- Table 16: United States Size of Population (million) , 2004- 2008(e)
39
- Table 17: United States GDP (Constant 2000 Prices, $ billion), 2004-
2008(e) 39
- Table 18: United States Inflation, 2004- 2008(e) 39
- Table 19: Mexico OTC Pharmaceuticals Market Value: $ billion, 2004-
2008(e) 41
- Table 20: Mexico OTC Pharmaceuticals Market Segmentation I: % Share, by
Value,
- 2008(e) 42
- Table 21: Mexico OTC Pharmaceuticals Market Segmentation II: % Share, by
Value,
- 2008(e) 43
- Table 22: Mexico OTC Pharmaceuticals Market Share: % Share, by Value, 2007
44
- Table 23: Key Facts: Boehringer Ingelheim GmbH 52
- Table 24: Key Financials: Boehringer Ingelheim GmbH 54
- Table 25: Key Facts: Pfizer Inc 55
- Table 26: Key Financials: Pfizer Inc 57
- Table 27: Key Facts: Bayer AG 58
- Table 28: Key Financials: Bayer AG 61
- Table 29: Mexico OTC Pharmaceuticals Distribution: % Share, by Value,
2008(e) 62
- Table 30: Mexico OTC Pharmaceuticals Market Value Forecast: $ billion,
2008-2013 63
- Table 31: Mexico Size of Population (million) , 2004-2008(e) 64
- Table 32: Mexico GDP (Constant 2000 Prices, $ billion), 2004-2008(e)
64
- Table 33: Mexico Inflation, 2004-2008(e) 64
- Table 34: Mexico Exchange Rate, 2004-2008(e) 65
- Table 35: Canada OTC Pharmaceuticals Market Value: $ billion, 2004-
2008(e) 67
- Table 36: Canada OTC Pharmaceuticals Market Segmentation I: % Share, by
Value,
- 2008(e) 68
- Table 37: Canada OTC Pharmaceuticals Market Segmentation II: % Share, by
Value,
- 2008(e) 69
- Table 38: Canada OTC Pharmaceuticals Market Share: % Share, by Value, 2007
70
- Table 39: Key Facts: Pfizer Inc 77
- Table 40: Key Financials: Pfizer Inc 79
- Table 41: Key Facts: GlaxoSmithKline Plc 80
- Table 42: Key Financials: GlaxoSmithKline Plc 83
- Table 43: Key Facts: Jamieson Laboratories 84
- Table 44: Canada OTC Pharmaceuticals Distribution: % Share, by Value,
2008(e) 85
- Table 45: Canada OTC Pharmaceuticals Market Value Forecast: $ billion,
2008-2013 86
- Table 46: Canada Size of Population (million) , 2004- 2008(e) 87
- Table 47: Canada GDP (Constant 2000 Prices, $ billion), 2004- 2008(e) 87
- Table 48: Canada Inflation, 2004- 2008(e) 87
- Table 49: Canada Exchange Rate, 2004- 2008(e) 88
LIST OF FIGURES
- Figure 1: NAFTA countries OTC Pharmaceuticals industry, revenue ($bn) 2004
- 2013 12
- Figure 2: NAFTA countries OTC Pharmaceuticals industry, revenue ($ bn)
2004 - 2008(e)
- 13
- Figure 3: NAFTA countries OTC Pharmaceuticals industry forecast, revenue
($ bn) 2008 -
- 2013 14
- Figure 4: United States OTC Pharmaceuticals Market Value: $ billion,
2004-2008(e) 16
- Figure 5: United States OTC Pharmaceuticals Market Segmentation I: %
Share, by Value,
- 2008(e) 17
- Figure 6: United States OTC Pharmaceuticals Market Segmentation II: %
Share, by
- Value, 2008(e) 18
- Figure 7: United States OTC Pharmaceuticals Market Share: % Share, by
Value, 2007 19
- Figure 8: Forces Driving Competition in the OTC Pharmaceuticals Market in
the United
- States 20
- Figure 9: Drivers of Buyer Power in the OTC Pharmaceuticals Market in the
United States
- 21
- Figure 10: Drivers of Supplier Power in the OTC Pharmaceuticals Market in
the United
- States 22
- Figure 11: Factors Influencing the Likelihood of New Entrants in the OTC
Pharmaceuticals
- Market in the United States 23
- Figure 12: Factors Influencing the Threat of Substitutes in the OTC
Pharmaceuticals
- Market in the United States 25
- Figure 13: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market
in the United
- States 26
- Figure 14: Revenues & Profitability: Pfizer Inc 29
- Figure 15: Revenues & Profitability: GlaxoSmithKline Plc 33
- Figure 16: Revenues & Profitability: Wyeth 36
- Figure 17: United States OTC Pharmaceuticals Distribution: % Share, by
Value, 2008(e) 37
- Figure 18: United States OTC Pharmaceuticals Market Value Forecast: $
billion, 2008-
- 2013 38
- Figure 19: Mexico OTC Pharmaceuticals Market Value: $ billion, 2004-
2008(e) 41
- Figure 20: Mexico OTC Pharmaceuticals Market Segmentation I: % Share, by
Value,
- 2008(e) 42
- Figure 21: Mexico OTC Pharmaceuticals Market Segmentation II: % Share, by
Value,
- 2008(e) 43
- Figure 22: Mexico OTC Pharmaceuticals Market Share: % Share, by Value,
2007 44
- Figure 23: Forces Driving Competition in the OTC Pharmaceuticals Market in
Mexico 45
- Figure 24: Drivers of Buyer Power in the OTC Pharmaceuticals Market in
Mexico 46
- Figure 25: Drivers of Supplier Power in the OTC Pharmaceuticals Market in
Mexico 47
- Figure 26: Factors Influencing the Likelihood of New Entrants in the OTC
Pharmaceuticals
- Market in Mexico 48
- Figure 27: Factors Influencing the Threat of Substitutes in the OTC
Pharmaceuticals
- Market in Mexico 50
- Figure 28: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market
in Mexico 51
- Figure 29: Revenues & Profitability: Boehringer Ingelheim GmbH 54
- Figure 30: Revenues & Profitability: Pfizer Inc 57
- Figure 31: Revenues & Profitability: Bayer AG 61
- Figure 32: Mexico OTC Pharmaceuticals Distribution: % Share, by Value,
2008(e) 62
- Figure 33: Mexico OTC Pharmaceuticals Market Value Forecast: $ billion,
2008-2013 63
- Figure 34: Canada OTC Pharmaceuticals Market Value: $ billion, 2004-
2008(e) 67
- Figure 35: Canada OTC Pharmaceuticals Market Segmentation I: % Share, by
Value,
- 2008(e) 68
- Figure 36: Canada OTC Pharmaceuticals Market Segmentation II: % Share, by
Value,
- 2008(e) 69
- Figure 37: Canada OTC Pharmaceuticals Market Share: % Share, by Value,
2007 70
- Figure 38: Forces Driving Competition in the OTC Pharmaceuticals Market in
Canada 71
- Figure 39: Drivers of Buyer Power in the OTC Pharmaceuticals Market in
Canada 72
- Figure 40: Drivers of Supplier Power in the OTC Pharmaceuticals Market in
Canada 73
- Figure 41: Factors Influencing the Likelihood of New Entrants in the OTC
Pharmaceuticals
- Market in Canada 74
- Figure 42: Factors Influencing the Threat of Substitutes in the OTC
Pharmaceuticals
- Market in Canada 75
- Figure 43: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market
in Canada 76
- Figure 44: Revenues & Profitability: Pfizer Inc 79
- Figure 45: Revenues & Profitability: GlaxoSmithKline Plc 83
- Figure 46: Canada OTC Pharmaceuticals Distribution: % Share, by Value,
2008(e) 85
- Figure 47: Canada OTC Pharmaceuticals Market Value Forecast: $ billion,
2008-2013 86
|
Related Report
|
View Cart
